$0.2655
0.008523.31%
Last update: Aug 28, 9:00 AM
Vistagen Therapeutics Inc (VTGN) Stock Price, Quote, News & History
VTGNNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Vistagen Therapeutics (VTGN) stock?
You can purchase shares of Vistagen Therapeutics (NASDAQ:VTGN) through any online brokerage.
Who are Vistagen Therapeutics (VTGN) competitors?
Other companies in Vistagen Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
What is the forecast, or price target, for Vistagen Therapeutics (VTGN) stock?
Vistagen Therapeutics has a consensus price target of $6.45.
What is the current price for Vistagen Therapeutics (VTGN)?
The stock price for Vistagen Therapeutics (NASDAQ: VTGN) is $0.265519 last updated August 28, 2026 at 9:00 AM EDT.
Does Vistagen Therapeutics (VTGN) pay a dividend?
There are no upcoming dividends for Vistagen Therapeutics.
When is Vistagen Therapeutics (NASDAQ:VTGN) reporting earnings?
Vistagen Therapeutics does not have any upcoming earnings scheduled.
Is Vistagen Therapeutics (VTGN) going to split?
There is no upcoming split for Vistagen Therapeutics.
What sector and industry does Vistagen Therapeutics (VTGN) operate in?
Vistagen Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
